The revision of CPT 29826 from a standalone code to an add-on code — +29826 (Arthroscopy, shoulder, surgical; decompression of subacromial space with partial acromioplasty, with coracoacromial ...

Please provide your email address to receive an email when new articles are posted on . Subacromial decompression with arthroscopic rotator cuff repair yielded a 21% risk reduction for revision ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Published results showed patients with shoulder ...

POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...

Arthroscopic subacromial decompression surgery does not reduce pain any more than arthroscopy alone in people with shoulder impingement, researchers say. "[T]he findings from our study suggest that ...

Dirk-Jan Hofstee, St. Elisabeth Hospital, Tilburg, The Netherlands; dj_hofstee{at}hotmail.com Objectives: The aim of this study was to evaluate whether removing the calcifications in the rotator cuff ...

Mika Paavola, Antti Malmivaara, Simo Taimela, Kari Kanto, Jari Inkinen, Juha Kalske, Ilkka Sinisaari, Vesa Savolainen, Jonas Ranstam, Teppo L N Järvinen and Finnish Shoulder Impingement Arthroscopy ...

Common surgery given to thousands of patients battling shoulder pain doesn't work, according to mounting evidence. Decompression surgery is used to manage the symptoms of the most common form of ...

Many countries have strict regulations to ensure new drugs are effective and are worth the money before doctors can prescribe them. But surgical procedures are often less strictly regulated. This can ...

A new study claims patients undergoing one of the most common surgical procedures in the western world might be wasting their time. A team of researchers from the University of Helsinki has spent the ...

CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved POSIMIR® (bupivacaine solution) for ...